BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2387816)

  • 1. Use of central venous catheters for prolonged venous access in cancer chemotherapy.
    Rajoor BG; Charak BS; Banavali SD; Iyer RS; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1990 May; 38(5):340-2. PubMed ID: 2387816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
    Ge F; Cang J; Xue ZG
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Implantable catheter systems].
    Willnow U
    Praxis (Bern 1994); 1998 Sep; 87(36):1135-9. PubMed ID: 9782741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Permanent venous access through a +portacath reservoir in patients receiving prolonged chemotherapy].
    García H; Díaz R; Pablo Barés J; Nevah E; Fábrega JM
    Rev Med Panama; 1994 Jan; 19(1):8-12. PubMed ID: 7938718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged venous access in cancer patients.
    Guenier C; Ferreira J; Pector JC
    Eur J Surg Oncol; 1989 Dec; 15(6):553-5. PubMed ID: 2599125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Totally implanted device for long-term intravenous chemotherapy: experience in 123 adult patients with solid neoplasms.
    Puig-la Calle J; López Sánchez S; Piedrafita Serra E; Allende Honorato L; Artigas Raventós V; Puig la Calle J
    J Surg Oncol; 1996 Aug; 62(4):273-8. PubMed ID: 8691841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgically implanted subcutaneous venous access devices in cancer patients.
    Repelaer van Driel OJ; Kuin CM; van de Velde CJ
    Neth J Surg; 1988 Jun; 40(4):97-9. PubMed ID: 3217033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of implantable chemotherapy reservoirs. Experience at the Hotel-Dieu of France].
    Antakly MC; Yazbeck P; Hayeck G; Yazigi A; Cherfane A
    J Med Liban; 1992; 40(2):108-11. PubMed ID: 1339879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Implanted venous access system in oncology. Review of 296 cases].
    Guenier C; Nogaret JM; Ferreira J; Lorent I; Pector JC
    Ann Chir; 1990; 44(5):388-91. PubMed ID: 2372203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term venous access.
    Raad I; Davis S; Becker M; Hohn D; Houston D; Umphrey J; Bodey GP
    Arch Intern Med; 1993 Aug; 153(15):1791-6. PubMed ID: 8392831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective study of untunnelled subclavian vein catheters in hematooncology patients.
    Huijgens PC; Strack van Schijndel R; Kampman I; Ossenkoppele GJ; Klomp-Gerringa M; van der Putten E
    Neth J Med; 1991 Apr; 38(3-4):153-8. PubMed ID: 1881503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malpositioning of Hickman catheters, left versus right sided attempts.
    Unal AE; Bayar S; Arat M; Ilhan O
    Transfus Apher Sci; 2003 Feb; 28(1):9-12. PubMed ID: 12620263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic therapy. Role of durable venous access.
    Rao VK; Charak BS; Giri NK; Banavali SD; Pai SK; Pai VR; Nadkarni KS; Kurkure PA; Saikia TK; Gopal R
    J Assoc Physicians India; 1990 Dec; 38(12):897-9. PubMed ID: 2096122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long term central venous catheterization revisited].
    Palermo S; Campolucci A; Capozza F; Cammardella MP; Balestrero A; Ferrando F; Basta P; Launo C
    Minerva Anestesiol; 1995 Nov; 61(11):451-6. PubMed ID: 8677035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
    Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
    Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The central venous catheter in the treatment of patients with malignancies].
    van Klaveren RJ; de Mulder PH; Wobbes T; Speth PA
    Ned Tijdschr Geneeskd; 1989 Aug; 133(33):1629-33. PubMed ID: 2677778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
    Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
    Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.